CL-4 Cancer Treatment

What is CL-4 Cancer Treatment

CL-4 cancer treatment - What is Cl 4 in cancer treatment? CL4 is a resistant RNA-aptamer nuclease that specifically binds to EGFR, with a constant mandatory 10 nM character. When applied expresses EGFR cancer cells to aptamer inhibits EGFR mediated by signal pathways by selectively causing cell death. In addition, at low doses induce even apoptosis of cells that are resistant to the most commonly used EGFR-inhibitors such as gefitinib and cetuximab, and inhibit tumor growth in a non-human model Xenograft Mouse ( NSCLC). Interestingly, combined treatment with cetuximab and Aptamer clearly shows synergy in inducing apoptosis in vitro and in vivo.

A new cancer treatment has been developed that can kill tumors in just two hours. CL-4 Cancer Treatment. The remarkable technique is non-invasive and requires only one blow and a beam of light. It may be of particular help to patients with inoperable or hard to reach increases, as well as children hit by diseases, reveals a study. The biologist, Professor Matthew Gdovin recently tested a patented method against breast cancer triple negative, one of the most aggressive cancers and the most difficult to cure. (It is important for you to know, that on this page we only discuss cancer treatment with CL 4, for examples the facts guideline related to CL4 will also be discussed in a simple way). Let's read more!

In mice experiments, he was able to stop growth tumor and double their chances of survival after just a treatment in the laboratory. CL-4 Cancer Treatment? The new treatment involves injecting a chemical, nitrobenzaldehyde, into tumors and allowing it to diffuse into the tissue. Prof. Gdovin then pursues a beam of ultraviolet light to the cancerous cells, making them become very acidic and essentially commit suicide. See Also: Best Anti Cancer Foods.

Within two hours, he estimates that up to 95% of those targeted cancer cells are dead. Prof. Gdovin, from the University of Texas, San Antonio, said: "Even though there are many different types of cancer, they have one thing in common is their sensitivity to this induced cell suicide."

CL-4 Cancer Treatment

He added: "All forms of cancer attempt to make acidic cells on the outside as a way to draw the attention of a blood vessel, trying to escape the acid." Instead, cancer has laid eyes on the blood vessel and uses it to make the tumors bigger and bigger. " Target chemotherapy treatments all cells in the body, and certain therapeutics try to keep those diseased acidic as a way to kill them.

This is what makes many patients lose their hair and become sick. Prof. Gdovin method is more accurate and can only target the tumor. CL-4 Cancer Treatment. In the last two years, he has developed his own ' photodynamic therapy, to the point where it is non-invasive.

Now it only requires a liquid nitrobenzaldehyde injection, followed by a flash of ultraviolet light to cause cancer killing reaction. He began to test the method of drug-resistant cancer cells to make therapy as potent as possible. It could also help people who have received the maximum amount of radiation and can no longer cope with scars and pains that go along with it, or children who are at risk of developing radiation mutations because they grow older.

Added Prof. Gdovin: "There are so many types of cancer, for which the prognosis is very weak. We're thinking outside the box and finding a way to do what for many people is simply impossible." Meanwhile, other scientists have sustained the deadly toxin anthrax could hold the key to fighting cancer. Researchers have discovered that by combining anthrax proteins with chemotherapy drugs could remove or reduce tumors.

CL-4 Cancer Treatment - Using mice, the team from the National Institutes of Health, found that the protein engineered the target anthrax cells that lining the inner walls of the blood vessels that nourish the tumor. However, on their own produce an immune response, but to get around this have been combined with chemotherapy medications. The research, published in the Proceedings of the National Academy of Sciences, showed that this product "durable, anti-tumor effects worthy of exploration".